Search

Search Constraints

You searched for: Author/Creator Migkou, Magdalini

Search Results

11. Detection of MYD88 and CXCR4 mutations in cell-free DNA of patients with IgM monoclonal gammopathies. Issue 12 (December 2018)

12. Efficacy of lenalidomide as salvage therapy for patients with AL amyloidosis. (2nd October 2018)

13. Genetic factors related with early onset of osteonecrosis of the jaw in patients with multiple myeloma under zoledronic acid therapy. Issue 10 (3rd October 2017)

14. Hematologic and renal improvement of monoclonal immunoglobulin deposition disease after treatment with bortezomib-based regimens. Issue 8 (3rd August 2017)

16. Impact of Minimal Residual Disease Detection by Next-Generation Flow Cytometry in Multiple Myeloma Patients with Sustained Complete Remission after Frontline Therapy. Issue 6 (December 2019)

17. Kinetics of anti‐SARS‐CoV‐2 neutralizing antibodies development after BNT162b2 vaccination in patients with amyloidosis and the impact of therapy. Issue 1 (23rd November 2021)

18. Lenalidomide with low- or intermediate-dose dexamethasone in patients with relapsed or refractory myeloma. Issue 8 (2nd August 2016)

19. Long‐term outcomes of primary systemic light chain (AL) amyloidosis in patients treated upfront with bortezomib or lenalidomide and the importance of risk adapted strategies. Issue 4 (9th March 2015)

20. Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine. (16th September 2021)